ID   CLK1_HUMAN              Reviewed;         484 AA.
AC   P49759; B4DFW7; Q0P694; Q8N5V8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 2.
DT   12-OCT-2022, entry version 203.
DE   RecName: Full=Dual specificity protein kinase CLK1;
DE            EC=2.7.12.1;
DE   AltName: Full=CDC-like kinase 1;
GN   Name=CLK1; Synonyms=CLK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1704889; DOI=10.1016/s0021-9258(19)67807-5;
RA   Johnson K.W., Smith K.A.;
RT   "Molecular cloning of a novel human cdc2/CDC28-like protein kinase.";
RL   J. Biol. Chem. 266:3402-3407(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=7990150; DOI=10.1006/jmbi.1994.1763;
RA   Hanes J.J., der Kammer H., Klaudiny J.J., Scheit K.H.;
RT   "Characterization by cDNA cloning of two new human protein kinases.
RT   Evidence by sequence comparison of a new family of mammalian protein
RT   kinases.";
RL   J. Mol. Biol. 244:665-672(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Blood, and Bone;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=10480872; DOI=10.1074/jbc.274.38.26697;
RA   Moeslein F.M., Myers M.P., Landreth G.E.;
RT   "The CLK family kinases, CLK1 and CLK2, phosphorylate and activate the
RT   tyrosine phosphatase, PTP-1B.";
RL   J. Biol. Chem. 274:26697-26704(1999).
RN   [8]
RP   INTERACTION WITH UBL5.
RX   PubMed=12705895; DOI=10.1016/s0006-291x(03)00549-7;
RA   Kantham L., Kerr-Bayles L., Godde N., Quick M., Webb R., Sunderland T.,
RA   Bond J., Walder K., Augert G., Collier G.;
RT   "Beacon interacts with cdc2/cdc28-like kinases.";
RL   Biochem. Biophys. Res. Commun. 304:125-129(2003).
RN   [9]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-61 AND SER-140, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-138 AND SER-140, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   FUNCTION, ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=19168442; DOI=10.1161/circresaha.108.183905;
RA   Eisenreich A., Bogdanov V.Y., Zakrzewicz A., Pries A., Antoniak S.,
RA   Poller W., Schultheiss H.P., Rauch U.;
RT   "Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of
RT   tissue factor in human endothelial cells.";
RL   Circ. Res. 104:589-599(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   VARIANTS [LARGE SCALE ANALYSIS] PHE-61; GLY-118; SER-307 AND THR-440.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Dual specificity kinase acting on both serine/threonine and
CC       tyrosine-containing substrates. Phosphorylates serine- and arginine-
CC       rich (SR) proteins of the spliceosomal complex and may be a constituent
CC       of a network of regulatory mechanisms that enable SR proteins to
CC       control RNA splicing. Phosphorylates: SRSF1, SRSF3 and PTPN1. Regulates
CC       the alternative splicing of tissue factor (F3) pre-mRNA in endothelial
CC       cells and adenovirus E1A pre-mRNA. {ECO:0000269|PubMed:10480872,
CC       ECO:0000269|PubMed:19168442}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.12.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC   -!- ACTIVITY REGULATION: Regulates splicing of its own pre-mRNA according
CC       to its kinase activity; increased expression of the catalytically
CC       active form influences splicing to generate the catalytically inactive
CC       splicing variant lacking the kinase domain. Leucettine L41 inhibits its
CC       kinase activity and affects the regulation of alternative splicing
CC       mediated by phosphorylation of SR proteins (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with PPIG and UBL5. {ECO:0000269|PubMed:12705895}.
CC   -!- INTERACTION:
CC       P49759; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-473775, EBI-10172290;
CC       P49759; O76083: PDE9A; NbExp=3; IntAct=EBI-473775, EBI-742764;
CC       P49759-3; Q8N2M8: CLASRP; NbExp=3; IntAct=EBI-11981867, EBI-751069;
CC       P49759-3; P49760: CLK2; NbExp=5; IntAct=EBI-11981867, EBI-750020;
CC       P49759-3; Q92997: DVL3; NbExp=3; IntAct=EBI-11981867, EBI-739789;
CC       P49759-3; P60371: KRTAP10-6; NbExp=3; IntAct=EBI-11981867, EBI-12012928;
CC       P49759-3; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-11981867, EBI-10172290;
CC       P49759-3; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-11981867, EBI-739832;
CC       P49759-3; O76083-2: PDE9A; NbExp=3; IntAct=EBI-11981867, EBI-11524542;
CC       P49759-3; O14492-2: SH2B2; NbExp=3; IntAct=EBI-11981867, EBI-19952306;
CC       P49759-3; A7MD48: SRRM4; NbExp=3; IntAct=EBI-11981867, EBI-3867173;
CC       P49759-3; Q07955: SRSF1; NbExp=3; IntAct=EBI-11981867, EBI-398920;
CC       P49759-3; O75494: SRSF10; NbExp=3; IntAct=EBI-11981867, EBI-353655;
CC       P49759-3; P84103: SRSF3; NbExp=3; IntAct=EBI-11981867, EBI-372557;
CC       P49759-3; Q16629: SRSF7; NbExp=3; IntAct=EBI-11981867, EBI-398885;
CC       P49759-3; P62995: TRA2B; NbExp=5; IntAct=EBI-11981867, EBI-725485;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Long;
CC         IsoId=P49759-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P49759-2; Sequence=VSP_004852, VSP_004853;
CC       Name=3;
CC         IsoId=P49759-3; Sequence=VSP_043578;
CC   -!- TISSUE SPECIFICITY: Endothelial cells. {ECO:0000269|PubMed:19168442}.
CC   -!- PTM: Autophosphorylates on all three types of residues. {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Lacks the kinase domain. May be produced at
CC       very low levels due to a premature stop codon in the mRNA, leading to
CC       nonsense-mediated mRNA decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. Lammer subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L29219; AAA61480.1; -; mRNA.
DR   EMBL; L29222; AAB59459.1; -; mRNA.
DR   EMBL; AK289365; BAF82054.1; -; mRNA.
DR   EMBL; AK294295; BAG57578.1; -; mRNA.
DR   EMBL; AC005037; AAY14722.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70217.1; -; Genomic_DNA.
DR   EMBL; BC028149; AAH28149.1; -; mRNA.
DR   EMBL; BC031549; AAH31549.1; -; mRNA.
DR   CCDS; CCDS2331.1; -. [P49759-1]
DR   CCDS; CCDS54427.1; -. [P49759-3]
DR   PIR; S53641; S53641.
DR   RefSeq; NP_001155879.1; NM_001162407.1. [P49759-3]
DR   RefSeq; NP_004062.2; NM_004071.3. [P49759-1]
DR   PDB; 1Z57; X-ray; 1.70 A; A=148-484.
DR   PDB; 2VAG; X-ray; 1.80 A; A=148-484.
DR   PDB; 5J1V; X-ray; 2.52 A; A/B/C=148-484.
DR   PDB; 5J1W; X-ray; 2.42 A; A/B/C=148-484.
DR   PDB; 5X8I; X-ray; 1.90 A; A/B=148-484.
DR   PDB; 6FT8; X-ray; 1.45 A; A=148-484.
DR   PDB; 6FT9; X-ray; 1.87 A; A/B/C=148-484.
DR   PDB; 6FYO; X-ray; 2.32 A; A=148-484.
DR   PDB; 6G33; X-ray; 2.05 A; A/B/C=148-484.
DR   PDB; 6I5H; X-ray; 1.49 A; A=148-484.
DR   PDB; 6I5I; X-ray; 1.60 A; A=148-484.
DR   PDB; 6I5K; X-ray; 2.30 A; A/B/C=148-484.
DR   PDB; 6I5L; X-ray; 2.55 A; A/B/C=148-484.
DR   PDB; 6KHD; X-ray; 2.70 A; A/B/C=1-484.
DR   PDB; 6Q8K; X-ray; 2.29 A; A=148-484.
DR   PDB; 6Q8P; X-ray; 3.00 A; A/B/C=148-484.
DR   PDB; 6QTY; X-ray; 1.65 A; A=148-484.
DR   PDB; 6R3D; X-ray; 1.85 A; A=148-484.
DR   PDB; 6R6E; X-ray; 2.25 A; A=148-484.
DR   PDB; 6R6X; X-ray; 2.05 A; A=148-484.
DR   PDB; 6R8J; X-ray; 1.75 A; A=148-484.
DR   PDB; 6RAA; X-ray; 2.10 A; A=148-484.
DR   PDB; 6TW2; X-ray; 1.80 A; E=148-484.
DR   PDB; 6YTA; X-ray; 2.30 A; A=148-484.
DR   PDB; 6YTD; X-ray; 2.00 A; A=148-484.
DR   PDB; 6YTE; X-ray; 2.30 A; C=148-484.
DR   PDB; 6YTG; X-ray; 1.95 A; A=148-484.
DR   PDB; 6YTI; X-ray; 2.40 A; A=148-484.
DR   PDB; 6Z4Z; X-ray; 2.07 A; A/B/C=148-484.
DR   PDB; 6Z50; X-ray; 1.60 A; A=148-484.
DR   PDB; 6ZLN; X-ray; 1.70 A; A=148-484.
DR   PDB; 7AK3; X-ray; 2.50 A; A=148-484.
DR   PDB; 7OPG; X-ray; 1.93 A; A/B/C=148-484.
DR   PDBsum; 1Z57; -.
DR   PDBsum; 2VAG; -.
DR   PDBsum; 5J1V; -.
DR   PDBsum; 5J1W; -.
DR   PDBsum; 5X8I; -.
DR   PDBsum; 6FT8; -.
DR   PDBsum; 6FT9; -.
DR   PDBsum; 6FYO; -.
DR   PDBsum; 6G33; -.
DR   PDBsum; 6I5H; -.
DR   PDBsum; 6I5I; -.
DR   PDBsum; 6I5K; -.
DR   PDBsum; 6I5L; -.
DR   PDBsum; 6KHD; -.
DR   PDBsum; 6Q8K; -.
DR   PDBsum; 6Q8P; -.
DR   PDBsum; 6QTY; -.
DR   PDBsum; 6R3D; -.
DR   PDBsum; 6R6E; -.
DR   PDBsum; 6R6X; -.
DR   PDBsum; 6R8J; -.
DR   PDBsum; 6RAA; -.
DR   PDBsum; 6TW2; -.
DR   PDBsum; 6YTA; -.
DR   PDBsum; 6YTD; -.
DR   PDBsum; 6YTE; -.
DR   PDBsum; 6YTG; -.
DR   PDBsum; 6YTI; -.
DR   PDBsum; 6Z4Z; -.
DR   PDBsum; 6Z50; -.
DR   PDBsum; 6ZLN; -.
DR   PDBsum; 7AK3; -.
DR   PDBsum; 7OPG; -.
DR   AlphaFoldDB; P49759; -.
DR   SMR; P49759; -.
DR   BioGRID; 107606; 197.
DR   IntAct; P49759; 54.
DR   MINT; P49759; -.
DR   STRING; 9606.ENSP00000394734; -.
DR   BindingDB; P49759; -.
DR   ChEMBL; CHEMBL4224; -.
DR   DrugBank; DB06376; CHGN111.
DR   DrugBank; DB04367; Debromohymenialdisine.
DR   DrugBank; DB08691; ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; P49759; -.
DR   GuidetoPHARMACOLOGY; 1990; -.
DR   GlyGen; P49759; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P49759; -.
DR   PhosphoSitePlus; P49759; -.
DR   BioMuta; CLK1; -.
DR   DMDM; 206729857; -.
DR   EPD; P49759; -.
DR   jPOST; P49759; -.
DR   MassIVE; P49759; -.
DR   MaxQB; P49759; -.
DR   PaxDb; P49759; -.
DR   PeptideAtlas; P49759; -.
DR   PRIDE; P49759; -.
DR   ProteomicsDB; 56090; -. [P49759-1]
DR   ProteomicsDB; 56091; -. [P49759-2]
DR   ProteomicsDB; 56092; -. [P49759-3]
DR   Antibodypedia; 34923; 221 antibodies from 28 providers.
DR   DNASU; 1195; -.
DR   Ensembl; ENST00000321356.9; ENSP00000326830.4; ENSG00000013441.17. [P49759-1]
DR   Ensembl; ENST00000432425.5; ENSP00000400487.1; ENSG00000013441.17. [P49759-2]
DR   Ensembl; ENST00000434813.3; ENSP00000394734.2; ENSG00000013441.17. [P49759-3]
DR   GeneID; 1195; -.
DR   KEGG; hsa:1195; -.
DR   MANE-Select; ENST00000321356.9; ENSP00000326830.4; NM_004071.4; NP_004062.2.
DR   UCSC; uc002uwe.3; human. [P49759-1]
DR   CTD; 1195; -.
DR   DisGeNET; 1195; -.
DR   GeneCards; CLK1; -.
DR   HGNC; HGNC:2068; CLK1.
DR   HPA; ENSG00000013441; Low tissue specificity.
DR   MIM; 601951; gene.
DR   neXtProt; NX_P49759; -.
DR   OpenTargets; ENSG00000013441; -.
DR   PharmGKB; PA26594; -.
DR   VEuPathDB; HostDB:ENSG00000013441; -.
DR   eggNOG; KOG0671; Eukaryota.
DR   GeneTree; ENSGT00940000159722; -.
DR   HOGENOM; CLU_126079_0_0_1; -.
DR   InParanoid; P49759; -.
DR   OMA; YHNHSSK; -.
DR   OrthoDB; 915778at2759; -.
DR   PhylomeDB; P49759; -.
DR   TreeFam; TF101041; -.
DR   BRENDA; 2.7.12.1; 2681.
DR   PathwayCommons; P49759; -.
DR   SignaLink; P49759; -.
DR   SIGNOR; P49759; -.
DR   BioGRID-ORCS; 1195; 8 hits in 1113 CRISPR screens.
DR   ChiTaRS; CLK1; human.
DR   EvolutionaryTrace; P49759; -.
DR   GeneWiki; CLK1; -.
DR   GenomeRNAi; 1195; -.
DR   Pharos; P49759; Tchem.
DR   PRO; PR:P49759; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P49759; protein.
DR   Bgee; ENSG00000013441; Expressed in granulocyte and 201 other tissues.
DR   ExpressionAtlas; P49759; baseline and differential.
DR   Genevisible; P49759; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; TAS:ProtInc.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IBA:GO_Central.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0043484; P:regulation of RNA splicing; IMP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Tyrosine-protein kinase.
FT   CHAIN           1..484
FT                   /note="Dual specificity protein kinase CLK1"
FT                   /id="PRO_0000085866"
FT   DOMAIN          161..477
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..42
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          79..146
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..24
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        79..100
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        110..136
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        288
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         167..175
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         191
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         61
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   MOD_RES         138
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         140
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1
FT                   /note="M -> MAAGRRPASALWPERRGSPLRGDLLGFQNVREPSSCGETLSGM (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043578"
FT   VAR_SEQ         131..136
FT                   /note="KSHRRK -> MKLLIL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:7990150"
FT                   /id="VSP_004852"
FT   VAR_SEQ         137..484
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:7990150"
FT                   /id="VSP_004853"
FT   VARIANT         61
FT                   /note="S -> F (in dbSNP:rs55989135)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040409"
FT   VARIANT         99
FT                   /note="N -> D (in dbSNP:rs6735666)"
FT                   /id="VAR_046551"
FT   VARIANT         118
FT                   /note="R -> G (in dbSNP:rs56135616)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040410"
FT   VARIANT         307
FT                   /note="P -> S (in dbSNP:rs35412475)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040411"
FT   VARIANT         440
FT                   /note="M -> T (in dbSNP:rs35393352)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040412"
FT   VARIANT         459
FT                   /note="E -> G (in dbSNP:rs12709)"
FT                   /id="VAR_051620"
FT   CONFLICT        432
FT                   /note="R -> A (in Ref. 1; AAA61480)"
FT                   /evidence="ECO:0000305"
FT   HELIX           148..150
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   TURN            158..160
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   STRAND          161..170
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   STRAND          173..180
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   TURN            181..185
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   STRAND          187..193
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   HELIX           197..216
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   STRAND          222..224
FT                   /evidence="ECO:0007829|PDB:6Z50"
FT   STRAND          227..233
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   STRAND          236..242
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   HELIX           248..254
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   TURN            255..257
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   HELIX           262..281
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   HELIX           291..293
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   STRAND          294..297
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   STRAND          301..306
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   TURN            307..310
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   STRAND          311..317
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   STRAND          321..323
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   STRAND          330..334
FT                   /evidence="ECO:0007829|PDB:6YTE"
FT   HELIX           343..345
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   HELIX           348..351
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   HELIX           359..374
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   HELIX           384..395
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   HELIX           400..405
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   HELIX           409..411
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   STRAND          421..423
FT                   /evidence="ECO:0007829|PDB:6YTI"
FT   HELIX           424..432
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   HELIX           436..439
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   HELIX           445..457
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   TURN            462..464
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   HELIX           468..471
FT                   /evidence="ECO:0007829|PDB:6FT8"
FT   HELIX           475..481
FT                   /evidence="ECO:0007829|PDB:6FT8"
SQ   SEQUENCE   484 AA;  57291 MW;  F34B5B44988BD118 CRC64;
     MRHSKRTYCP DWDDKDWDYG KWRSSSSHKR RKRSHSSAQE NKRCKYNHSK MCDSHYLESR
     SINEKDYHSR RYIDEYRNDY TQGCEPGHRQ RDHESRYQNH SSKSSGRSGR SSYKSKHRIH
     HSTSHRRSHG KSHRRKRTRS VEDDEEGHLI CQSGDVLSAR YEIVDTLGEG AFGKVVECID
     HKAGGRHVAV KIVKNVDRYC EAARSEIQVL EHLNTTDPNS TFRCVQMLEW FEHHGHICIV
     FELLGLSTYD FIKENGFLPF RLDHIRKMAY QICKSVNFLH SNKLTHTDLK PENILFVQSD
     YTEAYNPKIK RDERTLINPD IKVVDFGSAT YDDEHHSTLV STRHYRAPEV ILALGWSQPC
     DVWSIGCILI EYYLGFTVFP THDSKEHLAM MERILGPLPK HMIQKTRKRK YFHHDRLDWD
     EHSSAGRYVS RRCKPLKEFM LSQDVEHERL FDLIQKMLEY DPAKRITLRE ALKHPFFDLL
     KKSI
//
